Microglia activation in a model of retinal degeneration and TUDCA neuroprotective effects.
Microglia activation in a model of retinal degeneration and TUDCA neuroprotective effects.
复制标题
DOI:
10.1186/s12974-014-0186-3
复制
发表时间:
2014-10-29
影响因子:
9.3
通讯作者:
Cuenca N
中科院分区:
文献类型:
--
作者:
Noailles A;Fernández-Sánchez L;Lax P;Cuenca N
Retinitis pigmentosa is a heterogeneous group of inherited neurodegenerative retinal disorders characterized by a progressive peripheral vision loss and night vision difficulties, subsequently leading to central vision impairment. Chronic microglia activation is associated with various neurodegenerative diseases including retinitis pigmentosa. The objective of this study was to quantify microglia activation in the retina of P23H rats, an animal model of retinitis pigmentosa, and to evaluate the therapeutic effects of TUDCA (tauroursodeoxycholic acid), which has been described as a neuroprotective compound. For this study, homozygous P23H line 3 and Sprague-Dawley (SD) rats were injected weekly with TUDCA (500 mg/kg, ip) or vehicle (saline) from 20 days to 4 months old. Vertical retinal sections and whole-mount retinas were immunostained for specific markers of microglial cells (anti-CD11b, anti-Iba1 and anti-MHC-II). Microglial cell morphology was analyzed and the number of retinal microglial was quantified. Microglial cells in the SD rat retinas were arranged in regular mosaics homogenously distributed within the plexiform and ganglion cell layers. In the P23H rat retina, microglial cells increased in number in all layers compared with control SD rat retinas, preserving the regular mosaic distribution. In addition, a large number of amoeboid CD11b-positive cells were observed in the P23H rat retina, even in the subretinal space. Retinas of TUDCA-treated P23H animals exhibited lower microglial cell number in all layers and absence of microglial cells in the subretinal space. These results report novel TUDCA anti-inflammatory actions, with potential therapeutic implications for neurodegenerative diseases, including retinitis pigmentosa.
登录
查看更多内容
DOI:
10.4172/2155-9899
发表时间:
2013
期刊:
Journal of clinical & cellular immunology
影响因子:
--
作者:
Abcouwer SF
通讯作者:
Abcouwer SF
影响因子:
13.5
作者:
Harry, G. Jean
通讯作者:
Harry, G. Jean
影响因子:
3.3
作者:
Hayashi, Y.;Tomimatsu, Y.;Nakanishi, H.
通讯作者:
Nakanishi, H.
影响因子:
3.3
作者:
Gaspar, J. M.;Martins, A.;Santiago, A. R.
通讯作者:
Santiago, A. R.
影响因子:
2.5
作者:
Bosco, Alejandra;Steele, Michael R.;Vetter, Monica L.
通讯作者:
Vetter, Monica L.